Treatment for Seminal Vasculitis
For seminal vasculitis, treatment should follow the established protocols for small and medium vessel vasculitis, with cyclophosphamide and glucocorticoids as the first-line therapy for severe disease, or less toxic alternatives like methotrexate for non-severe cases. 1
Disease Classification and Initial Approach
- Seminal vasculitis should be categorized according to severity (non-severe vs. severe) to guide appropriate treatment decisions 1
- Management should ideally involve collaboration with centers of expertise in vasculitis 1
- Diagnostic evaluation should include ANCA testing and potentially biopsy to confirm the diagnosis 1
Treatment Recommendations Based on Disease Severity
For Severe Seminal Vasculitis:
- First-line therapy: Combination of cyclophosphamide (intravenous or oral) and glucocorticoids 1
- Consider Mesna as a uroprotective agent when using cyclophosphamide to reduce bladder toxicity 1
- For refractory cases, rituximab is an effective alternative 1, 2
For Non-Severe Seminal Vasculitis:
- First-line therapy: Methotrexate (oral or parenteral) combined with glucocorticoids 1
- Alternative options include azathioprine or mycophenolate mofetil with glucocorticoids 1, 2
- For mild disease, consider colchicine or dapsone 2
Remission Maintenance Therapy
- Once remission is achieved, transition to maintenance therapy with 1:
- Low-dose glucocorticoids plus one of the following:
- Azathioprine (preferred option)
- Methotrexate
- Leflunomide
- Low-dose glucocorticoids plus one of the following:
Special Considerations
- If there is concurrent epididymitis (common with seminal vesiculitis), antimicrobial therapy may be necessary 3:
Monitoring and Follow-up
- Regular structured clinical assessments, urinalysis, and laboratory tests should be performed at each clinical visit 1
- Failure to improve within 3 days of antimicrobial therapy (if infectious etiology) requires reevaluation of diagnosis and treatment 1
- Monitor for cyclophosphamide toxicity, including regular urinalysis to detect hematuria which may indicate bladder cancer risk 1
Treatment for Refractory Disease
- For patients who fail to achieve remission on standard therapy, consider 1, 2:
- Rituximab
- Intravenous immunoglobulin
- Mycophenolate mofetil
- Plasmapheresis in severe cases